These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 19047992)

  • 1. Do microRNAs regulate myocardial fibrosis?
    Díez J
    Nat Clin Pract Cardiovasc Med; 2009 Feb; 6(2):88-9. PubMed ID: 19047992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of myocardial fibrosis by MicroRNAs.
    Bauersachs J
    J Cardiovasc Pharmacol; 2010 Nov; 56(5):454-9. PubMed ID: 20625314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The therapeutic potential of miRNAs in cardiac fibrosis: where do we stand?
    Wijnen WJ; Pinto YM; Creemers EE
    J Cardiovasc Transl Res; 2013 Dec; 6(6):899-908. PubMed ID: 23821466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs in cardiac remodeling and disease.
    Huang ZP; Neppl RL; Wang DZ
    J Cardiovasc Transl Res; 2010 Jun; 3(3):212-8. PubMed ID: 20560042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs and cardiac pathology.
    Latronico MV; Condorelli G
    Nat Rev Cardiol; 2009 Jun; 6(6):419-29. PubMed ID: 19434076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNAs challenge the status quo of therapeutic targeting.
    Sayed D; Rane S; Abdellatif M
    J Cardiovasc Transl Res; 2009 Mar; 2(1):100-7. PubMed ID: 20559973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-22 in cardiac remodeling and disease.
    Huang ZP; Wang DZ
    Trends Cardiovasc Med; 2014 Oct; 24(7):267-72. PubMed ID: 25218673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small engine, big power: microRNAs as regulators of cardiac diseases and regeneration.
    Joladarashi D; Thandavarayan RA; Babu SS; Krishnamurthy P
    Int J Mol Sci; 2014 Sep; 15(9):15891-911. PubMed ID: 25207600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miRNAs as therapeutic targets in ischemic heart disease.
    Frost RJ; van Rooij E
    J Cardiovasc Transl Res; 2010 Jun; 3(3):280-9. PubMed ID: 20560049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Function analysis of differentially expressed microRNAs in TGF-β1-induced cardiac fibroblasts differentiation.
    Liu S; Ke W; Liu Y; Zhao Z; An L; You X; Yang F; Yang X; Wang G; Zhao X
    Biosci Rep; 2019 Oct; 39(10):. PubMed ID: 31527065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA as a Therapeutic Target in Cardiac Remodeling.
    Chen C; Ponnusamy M; Liu C; Gao J; Wang K; Li P
    Biomed Res Int; 2017; 2017():1278436. PubMed ID: 29094041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implication of microRNAs in the development and potential treatment of radiation-induced heart disease.
    Kura B; Babal P; Slezak J
    Can J Physiol Pharmacol; 2017 Oct; 95(10):1236-1244. PubMed ID: 28679064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXCR6 deficiency attenuates pressure overload-induced monocytes migration and cardiac fibrosis through downregulating TNF-α-dependent MMP9 pathway.
    Wang JH; Su F; Wang S; Lu XC; Zhang SH; Chen D; Chen NN; Zhong JQ
    Int J Clin Exp Pathol; 2014; 7(10):6514-23. PubMed ID: 25400729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the role of pericardial miRNAs and exosomes in modulating cardiac fibrosis.
    Schoettler FI; Fatehi Hassanabad A; Jadli AS; Patel VB; Fedak PWM
    Cardiovasc Pathol; 2024; 73():107671. PubMed ID: 38906439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNAs: A Neoteric Approach to Understand Pathogenesis, Diagnose, and Treat Myocardial Infarction.
    Sayed-Pathan NI; Kumar P; Paknikar KM; Gajbhiye V
    J Cardiovasc Pharmacol; 2021 Dec; 78(6):773-781. PubMed ID: 34882110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated IgE promotes cardiac fibrosis by suppressing miR-486a-5p.
    Zhao H; Yang H; Geng C; Chen Y; Tang Y; Li Z; Pang J; Shu T; Nie Y; Liu Y; Jia K; Wang J
    Theranostics; 2021; 11(15):7600-7615. PubMed ID: 34158869
    [No Abstract]   [Full Text] [Related]  

  • 17. Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling.
    Li YY; McTiernan CF; Feldman AM
    Cardiovasc Res; 2000 May; 46(2):214-24. PubMed ID: 10773225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-221/222 Family Counteracts Myocardial Fibrosis in Pressure Overload-Induced Heart Failure.
    Verjans R; Peters T; Beaumont FJ; van Leeuwen R; van Herwaarden T; Verhesen W; Munts C; Bijnen M; Henkens M; Diez J; de Windt LJ; van Nieuwenhoven FA; van Bilsen M; Goumans MJ; Heymans S; González A; Schroen B
    Hypertension; 2018 Feb; 71(2):280-288. PubMed ID: 29255073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of microRNA in cardiac and skeletal muscle disease gene therapy.
    Huang ZP; Neppl RL; Wang DZ
    Methods Mol Biol; 2011; 709():197-210. PubMed ID: 21194029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA expression and function in cardiac ischemic injury.
    Yu S; Li G
    J Cardiovasc Transl Res; 2010 Jun; 3(3):241-5. PubMed ID: 20535240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.